RxDoctor Payments Data

Heather Seavolt-Michael, PA

Physician Assistant · Hagerstown, MDNPI 1265586341

Payments from drug & device makers

$284in general payments, 2019–2025

Across 15 payments — averaging $18.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$51
  • GSK$40
  • Exact Sciences$38
  • Phathom Pharmaceuticals, Inc.$37
  • AbbVie$31
  • Novo Nordisk$29
  • plus $59 from 3 others

What the payments were for

  • Food & beverage$284100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$284 in reported general payments places this provider in the 60th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$65,235
Medicare patients
457
Services billed
930

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban62$65,922
OzempicSemaglutide43$52,801
JanuviaSitagliptin Phosphate24$28,313
JardianceEmpagliflozin15$22,526
MounjaroTirzepatide21$21,621
LinzessLinaclotide19$14,410
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl168$10,197
Breo ElliptaFluticasone/Vilanterol11$7,127
Spiriva HandihalerTiotropium Bromide11$5,298
SuboxoneBuprenorphine Hcl/Naloxone Hcl20$5,246
Incruse ElliptaUmeclidinium Bromide12$3,732
Rosuvastatin Calcium172$3,380
Atorvastatin Calcium216$3,184
Duloxetine Hcl65$2,475
Pravastatin Sodium96$1,942

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$29$52,80143 claims
MerckJanuvia$51$28,31324 claims
AbbVieLinzess, Synthroid$31$16,15441 claims
GSKBreo Ellipta, Incruse Ellipta$40$10,86023 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Hagerstown

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →